2/12/2013

Luoxis Diagnostics, an Ampio Pharmaceuticals unit, has launched operations to market the Oxidation Reduction Potential diagnostics platform. The technology is designed for use in developing disposable testing strips and a point-of-care reader for various conditions.

Full Story:
RTT News

Related Summaries